CHROMADEX CORP |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
| Apr. 09 | Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating | MT |
Chart calendar Chromadex Corp
7.IKF6-yE1eo21drT7n2Jrh9PG21Tk_4CBBVjDcm1hLxo.WJlLv0NYGP3vM9eI-jMB8aGovj2Qru3vQByLPjU1dWl_yTSSYnMQxt0M9Q~3f29ae67103879a151b13c70fb2e3e1e
Upcoming events on Chromadex Corp
Past events on Chromadex Corp
| 2024-03-18 07:00 pm | Roth Conference |
| 2024-03-06 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-06 04:02 pm | Q4 2023 Earnings Release |
| 2024-02-12 02:00 pm | Non-Deal Roadshow - Renmark |
| 2024-01-31 | Lytham Partners Investor Select Conference |
| 2023-11-14 02:00 pm | Non-Deal Roadshow - Renmark |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:02 pm | Q3 2023 Earnings Release |
| 2023-08-16 02:00 pm | Non-Deal Roadshow - Renmark |
| 2023-08-14 12:00 pm | Non-Deal Roadshow - Renmark |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:02 pm | Q2 2023 Earnings Release |
| 2023-06-15 06:00 pm | Annual General Meeting |
| 2023-06-06 04:30 pm | LD Micro Invitational Conference |
| 2023-05-17 | Lytham Partners Spring Investor Conference |
| 2023-05-10 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-10 04:02 pm | Q1 2023 Earnings Release |
| 2023-03-13 02:00 pm | ROTH Conference - Fireside Chat |
| 2023-03-08 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-08 04:02 pm | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 46,3 46,1 0.39% | 59,3 59,1 0.26% | 67,4 68,4 -1.42% | 72,1 72,1 -0.05% | 83,6 83,1 0.53% | 97,1 |
|
EBITDA Million USD | Released Forecast Spread | -20,2 -22,3 9.51% | -9,62 -10,1 4.78% | -18,9 -19,8 4.36% | -9,97 -9,16 -8.89% | 1,90 0,67 183.58% | 4,41 |
|
EBIT Million USD | Released Forecast Spread | -31,3 -29,2 -7.32% | -19,9 -19,5 -1.84% | -27,1 -28,3 4.36% | -18,6 -18,9 1.68% | -5,60 -7,11 21.29% | -1,90 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,1 -30,4 -5.67% | -19,9 -19,7 -0.91% | -27,1 -28,6 5.11% | -16,5 -17,4 5.03% | -4,94 -7,07 30.15% | -1,09 |
|
Net income Million USD | Released Forecast Spread | -32,1 -30,1 -6.95% | -19,9 -19,6 -1.64% | -27,1 -28,6 5.12% | -16,5 -17,3 4.4% | -4,94 -6,62 25.4% | -1,81 |
|
EPS USD | Released Forecast Spread | -0,56 -0,53 -6.67% | -0,33 -0,32 -3.77% | -0,40 -0,43 6.04% | -0,24 -0,23 -3.07% | -0,07 -0,09 20.45% | 0,00 |
| Announcement Date | 10/03/20 | 10/03/21 | 09/03/22 | 08/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,8 18,8 -5.38% | 17,3 17,5 -1.51% | 16,7 18,9 -11.43% | 17,1 18,7 -8.94% | 21,0 20,9 0.58% | 22,6 19,3 16.74% | 20,3 19,5 4.1% | 19,5 20,4 -4.3% | 21,2 20,7 2.18% | 23,6 | 23,7 | 24,2 | 25,6 | 28,3 |
|
EBITDA Million USD | Released Forecast Spread | -3,45 -4,29 19.68% | -4,47 -3,81 -17.58% | -4,64 -3,24 -43.36% | -1,21 -1,39 13.51% | 0,35 0,53 -33.8% | -0,07 -0,94 92.7% | 0,22 -0,60 136.41% | 0,50 -0,29 271.24% | 1,25 0,05 2671.11% | 0,07 | 0,16 | 1,84 | 2,35 | 2,76 |
|
EBIT Million USD | Released Forecast Spread | -5,32 -6,63 19.84% | -7,73 -5,88 -31.48% | -6,39 -5,74 -11.24% | -3,07 -4,26 28.1% | -1,44 -1,76 17.99% | -1,97 -3,45 42.96% | -2,32 -3,15 26.39% | -1,15 -2,36 51.49% | -0,17 -1,70 90.09% | -1,74 | -1,24 | 0,32 | 0,79 | 0,67 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,33 -6,99 23.8% | -7,74 -6,41 -20.75% | -6,40 -5,87 -9% | -0,99 -3,98 75.25% | -1,42 -1,78 20.25% | -1,90 -3,56 46.56% | -2,19 -2,97 26.14% | -0,96 -2,17 55.75% | 0,11 -2,02 105.65% | -1,71 | -1,03 | 0,66 | 1,02 | 0,70 |
|
Net income Million USD | Released Forecast Spread | -5,33 -6,92 23.09% | -7,74 -6,13 -26.27% | -6,40 -5,91 -8.3% | -0,99 -4,37 77.47% | -1,42 -1,84 22.75% | -1,90 -3,56 46.58% | -2,19 -3,20 31.43% | -0,96 -2,40 60.12% | 0,11 -1,57 107.27% | -1,55 | -1,39 | 0,48 | 0,98 | 0,82 |
|
EPS USD | Released Forecast Spread | -0,08 -0,10 22.22% | -0,11 -0,09 -24.53% | -0,09 -0,09 -5.01% | -0,01 -0,06 84.45% | -0,02 -0,03 22.21% | -0,03 -0,05 37.5% | -0,03 -0,04 28.01% | -0,10 -0,03 -215.76% | 0,00 -0,02 - | -0,01 | -0,01 | 0,01 | 0,02 | 0,01 |
| Announcement Date | 09/03/22 | 12/05/22 | 10/08/22 | 02/11/22 | 08/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 06/03/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Chromadex Corp
- Stock Market
- Equities
- CDXC Stock
- CDXC Stock
- Calendar Chromadex Corp
